Government Purchasing Activity for H1N1 Antigens and Adjuvants
US DHHS Orders for Bulk Supply of 2009 H1N1 Influenza Vaccine Antigens and Squalene-containing Adjuvants
Manufacturer |
Bulk Vaccine Antigen |
Oil-In-Water Bulk Adjuvant |
Novartis |
$150 million |
$139 million |
GlaxoSmithKline |
$ 38 million |
$144 million |
Sanofi Pasteur |
$191 million |
|
CSL Biotherapies |
$180 million |
|
MedImmune |
$ 90 million |
|
Total |
$649 million |
$283 million |